T-Track® CMV in vitro diagnostic ELISpot kit (IVD)

Diagnostic test for the measurement of CMV-specific cell-mediated immunity based on the ELISpot method combined with the T-activation® Technology.

  • Sensitive and standardized ELISpot
  • High clinical sensitivity
  • Assessment of the functionality of a broad network of clinically-relevant CMV-specific effector cells (CD4+ and CD8+ T cells, NK and NKT-like cells)
  • HLA antigen-independent application
  • CE-marked IVD in Europe

Go to product


T-Track® ImmunoScan ELISpot kit

T-Track® ImmunoScan

The T-Track® ImmunoScan assay is a test to evaluate the functionality of cell-mediated immunity in the course of a natural or induced immune modulation.

  • Based on the T-Track® basic IFN-γ ELISpot assay combined with the T-activated® ImmunoScan Cocktail
  • Measures the response of effector cells of adaptive and innate immunity (CD4+ and CD8+ T cells, NK and NKT-like cells)
  • For research use only

Go to product


T-Track® human IFN-γ HiSpecificityPRO ELISpot kit

    The T-Track® ELISpot kit human IFN-γ HiSpecificityPRO is a highly standardized and sensitive ELISpot assay to analyze human IFN-γ-secreting cells.

    • All-in-one ELISpot kit
    • For comprehensive analysis of IFN-γ-secreting cells
    • Highest specifictiy
    • Low background
    • Standardized read-out
    • Available in 96-well solid and 12 x 8-well strip format
    • For research use only

    Go to product


    T-Track® human IFN-γ HiSpecificityPRO ELISpot plate

      The T-Track® ELISpot plate human IFN-γ HiSpecificityPRO for individualized ELISpot assays.

      • Ready-to-use precoated ELISpot plate
      • For comprehensive analysis of IFN-γ-secreting cells
      • Highest specifictiy
      • Low background
      • Standardized read-out
      • Available in 96-well solid and 12 x 8-well strip format

      Go to product


      T-activated® proteins and ImmunoScan cocktail

      • Modified by Lophius´ T-activation® Technology
      • Are actively processed by APC along the MHC class II and I (cross-presentation) pathways leading to a physiological and comprehensive stimulation
      • Activate simultaneously clinically-relevant populations of effector cells, including CD4+ and CD8+ T cells as well as NK and NKT-like cells
      • Lead to a robust and reliable stimulation of effector cells
      • Applicable for many immunological assays such as ELISpot, FACS and ELISA

      Go to products

      This function requires IE9 or higher.
      You can update your browser under:
      http://windows.microsoft.com/de-DE/internet-explorer/download-ie